Glenn Mattes's most recent trade in Tff Pharmaceuticals Inc was a trade of 16,000 Common Stock done at an average price of $4.8 . Disclosure was reported to the exchange on May 16, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tff Pharmaceuticals Inc | Glenn Mattes | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 4.78 per share. | 16 May 2022 | 16,000 | 36,000 (0%) | 0% | 4.8 | 76,480 | Common Stock |
| Tff Pharmaceuticals Inc | Glenn Mattes | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 7.10 per share. | 16 Sep 2021 | 10,000 | 20,000 (0%) | 0% | 7.1 | 71,000 | Common Stock |